FOLR1 and ovarian cancer: A recent study described a novel tandem CAR encoding an anti-FRα scFv, an anti-mesothelin scFv, and two peptide sequences of IL-12 to improve the efficacy, infiltration, persistence, and proliferation of CAR T cells in ovarian cancer [177].